StockData
Jupiter Neurosciences, Inc. logo

Jupiter Neurosciences, Inc. (JUNS) stock

JUNSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$1.52−0.18 (-10.59%)

Close on Nov 17, 2026Market cap $1.17MP/E –Yield –

Jupiter Neurosciences profit margin

Profit margin (net margin) is net income as a percentage of revenue.

For fiscal 2025 it was -39662.8%.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-39662.8%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-9380.9%–
Q1 FY2026Mar 31, 2026-11054.9%–

More Jupiter Neurosciences figures

See a number that looks wrong?